Literature DB >> 3980483

Sulfation and constitutive secretion of dopamine beta-hydroxylase from rat pheochromocytoma (PC12) cells.

E M McHugh, R McGee, P J Fleming.   

Abstract

The biosynthesis and secretion of dopamine beta-hydroxylase were investigated by radiolabeling rat pheochromocytoma (PC12) cells in culture. Intracellular dopamine beta-hydroxylase from a crude chromaffin vesicle fraction and secreted dopamine beta-hydroxylase from culture medium were immunoprecipitated using antiserum made against purified bovine soluble dopamine beta-hydroxylase. Analysis of the immunoprecipitated enzyme on sodium dodecyl sulfate-polyacrylamide gel electrophoresis showed that: 1) the membrane-bound form of the hydroxylase from crude secretory vesicle membrane extracts contained two nonidentical subunits in approximately stoichiometric amounts (Mr = 77,000 and 73,000); 2) the soluble hydroxylase from the lysate of these secretory vesicles was composed predominantly of a single subunit (Mr = 73,000); and 3) the hydroxylase secreted into the medium under resting conditions was also composed of a single subunit (approximate Mr = 73,000). All subunits of the multiple forms of hydroxylase were glycoproteins. Under resting conditions, the rate of secretion of hydroxylase was approximately 6% of total cellular enzyme/15 min. The secreted form of the hydroxylase incorporated [35S]sulfate, whereas no significant [35S]sulfate was incorporated into the cellular forms of enzyme. We propose that in addition to the dopamine beta-hydroxylase which is found in catecholamine storage vesicles and released during stimulus-coupled exocytosis, PC12 cells also have a constitutive secretory pathway for dopamine beta-hydroxylase and that the enzyme released by this second pathway is sulfated.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3980483

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Differential expression of the regulated catecholamine secretory pathway in different hereditary forms of pheochromocytoma.

Authors:  Graeme Eisenhofer; Thanh-Truc Huynh; Abdel Elkahloun; John C Morris; Gennady Bratslavsky; W Marston Linehan; Zhengping Zhuang; Brian M Balgley; Cheng S Lee; Massimo Mannelli; Jacques W M Lenders; Stefan R Bornstein; Karel Pacak
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-14       Impact factor: 4.310

Review 2.  Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management.

Authors:  Graeme Eisenhofer; Graham Rivers; Alejandro L Rosas; Zena Quezado; William M Manger; Karel Pacak
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

3.  Expression of human dopamine beta-hydroxylase in Drosophila Schneider 2 cells.

Authors:  B Li; S Tsing; A H Kosaka; B Nguyen; E G Osen; C Bach; H Chan; J Barnett
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

4.  Deglycosylated membranous and soluble dopamine beta-hydroxylase have identical apparent molecular weights.

Authors:  A M Oyarce; P J Fleming
Journal:  J Mol Neurosci       Date:  1989       Impact factor: 3.444

5.  Selective packaging of human growth hormone into synaptic vesicles in a rat neuronal (PC12) cell line.

Authors:  E S Schweitzer; R B Kelly
Journal:  J Cell Biol       Date:  1985-08       Impact factor: 10.539

6.  Tyrosine sulfation, a post-translational modification of microvillar enzymes in the small intestinal enterocyte.

Authors:  E M Danielsen
Journal:  EMBO J       Date:  1987-10       Impact factor: 11.598

7.  The primary structure of human dopamine-beta-hydroxylase: insights into the relationship between the soluble and the membrane-bound forms of the enzyme.

Authors:  A Lamouroux; A Vigny; N Faucon Biguet; M C Darmon; R Franck; J P Henry; J Mallet
Journal:  EMBO J       Date:  1987-12-20       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.